Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Neoplasms of the CNS

Free Subscription Articles published in J Nucl Med Retrieve available abstracts of 22 articles: HTML format

Single Articles

December 2022
1. NABAVIZADEH A, Bagley SJ, Doot RK, Ware JB, et al
   Distinguishing Progression from Pseudoprogression in Glioblastoma Using (18)F-Fluciclovine PET.
   J Nucl Med. 2022 Dec 22:jnumed.122.264812. doi: 10.2967/jnumed.122.264812.
   PubMed     Abstract available
   
   
   
2. BAILEY DL, Willowson KP, Harris M, Biggin C, et al
   (64)Cu Treatment Planning and (67)Cu Therapy with Radiolabelled SARTATE ([(64)Cu/(67)Cu]MeCOSAR-Octreotate) in Subjects with Unresectable Multifocal Meningioma - Initial Results for Human Imaging, Safety, Biodistribution and Radiation Dosimetry.
   J Nucl Med. 2022 Dec 2:jnumed.122.264586. doi: 10.2967/jnumed.122.264586.
   PubMed     Abstract available
   
   
   
3. SCHLURMANN T, Waschulzik B, Combs S, Gempt J, et al
   Diagnostic utility of amino acid PET in the differential diagnosis of recurrent brain metastases and treatment-related changes: a meta-analysis.
   J Nucl Med. 2022 Dec 2:jnumed.122.264803. doi: 10.2967/jnumed.122.264803.
   PubMed     Abstract available
   
   
   November 2022
4. KREBS S, Schwartz J, Grommes C, Young RJ, et al
   Detecting CXCR4 expression in meningioma on (68)Ga-Pentixafor PET.
   J Nucl Med. 2022 Nov 10. pii: jnumed.122.265127. doi: 10.2967/jnumed.122.265127.
   PubMed    
   
   
   August 2022
5. SHIN J, Parker MFL, Zhu I, Alanizi A, et al
   Antigen-dependent inducible T cell reporter system for PET imaging of breast cancer and glioblastoma.
   J Nucl Med. 2022 Aug 18. pii: jnumed.122.264284. doi: 10.2967/jnumed.122.264284.
   PubMed     Abstract available
   
   
   April 2022
6. ROSEN J, Ceccon G, Bauer EK, Werner JM, et al
   Cost-effectiveness of (18)F-FET PET for early treatment response assessment in glioma patients following adjuvant temozolomide chemotherapy.
   J Nucl Med. 2022 Apr 14. pii: jnumed.122.263790. doi: 10.2967/jnumed.122.263790.
   PubMed     Abstract available
   
   
   March 2022
7. ZARAGORI T, Verger A
   Reply to Letter to the Editor: "(18)F-FDOPA PET for the Noninvasive Prediction of Glioma Molecular Parameters: A Radiomics Study".
   J Nucl Med. 2022 Mar 17. pii: jnumed.122.264035. doi: 10.2967/jnumed.122.264035.
   PubMed    
   
   
   February 2022
8. FORAY C, Barca C, Winkeler A, Wagner S, et al
   Interrogating glioma-associated microglia/macrophage dynamics under CSF-1R therapy with multi-tracer in vivo PET/MR imaging.
   J Nucl Med. 2022 Feb 3. pii: jnumed.121.263318. doi: 10.2967/jnumed.121.263318.
   PubMed     Abstract available
   
   
   January 2022
9. LANGEN KJ, Mottaghy FM
   Letter to the Editor: "(18)F-FDOPA PET for the Noninvasive Prediction of Glioma Molecular Parameters: A Radiomics Study" [J Nucl Med 2022; 63:147-157].
   J Nucl Med. 2022 Jan 27. pii: jnumed.122.263837. doi: 10.2967/jnumed.122.263837.
   PubMed    
   
   
   November 2021
10. NIMMAGADDA S
    Imaging PD-L1 expression in melanoma brain metastases.
    J Nucl Med. 2021 Nov 5. pii: jnumed.121.263209. doi: 10.2967/jnumed.121.263209.
    PubMed    
    
    
    September 2021
11. NIENHUIS PH, Antunes IF, Glaudemans AWJM, Jalving M, et al
    (18)F-BMS986192 PET imaging of PD-L1 in metastatic melanoma patients with brain metastases treated with immune checkpoint inhibitors. A pilot study.
    J Nucl Med. 2021 Sep 9. pii: jnumed.121.262368. doi: 10.2967/jnumed.121.262368.
    PubMed     Abstract available
    
    
    August 2021
12. BAG AK, Wing MN, Sabin ND, Hwang SN, et al
    [(11)C]-Methionine PET for Identification of Pediatric High-Grade Glioma Recurrence.
    J Nucl Med. 2021 Aug 26. pii: jnumed.120.261891. doi: 10.2967/jnumed.120.261891.
    PubMed     Abstract available
    
    
    
13. PARIHAR AS, Schmidt LR, Dehdashti F, Wahl RL, et al
    Detection of additional primary neoplasms on (18)F-Fluciclovine PET/CT in patients with primary prostate cancer.
    J Nucl Med. 2021 Aug 19. pii: jnumed.121.262647. doi: 10.2967/jnumed.121.262647.
    PubMed     Abstract available
    
    
    
14. BRENDLE C, Maier C, Bender B, Schittenhelm J, et al
    Impact of (18)F-FET PET/MR on clinical management of brain tumor patients.
    J Nucl Med. 2021 Aug 5. pii: jnumed.121.262051. doi: 10.2967/jnumed.121.262051.
    PubMed     Abstract available
    
    
    July 2021
15. VONKEN EPA, Bruijnen RCG, Snijders TJ, Seute T, et al
    Intra-arterial administration boosts (177)Lu-HA-DOTATATE accumulation in salvage meningioma patients.
    J Nucl Med. 2021 Jul 22. pii: jnumed.121.262491. doi: 10.2967/jnumed.121.262491.
    PubMed     Abstract available
    
    
    
16. BASHARI WA, Senanayake R, MacFarlane J, Gillett D, et al
    Using Molecular Imaging to Enhance Decision Making in the Management of Pituitary Adenomas.
    J Nucl Med. 2021;62.
    PubMed     Abstract available
    
    
    May 2021
17. ZARAGORI T, Oster J, Roch V, Hossu G, et al
    (18)F-FDOPA PET for the non-invasive prediction of glioma molecular parameters: a radiomics study.
    J Nucl Med. 2021 May 20. pii: jnumed.120.261545. doi: 10.2967/jnumed.120.261545.
    PubMed     Abstract available
    
    
    
18. COLLET S, Guillamo JS, Berro DH, Chakhoyan A, et al
    Simultaneous mapping of vasculature, hypoxia and proliferation using DSC-MRI, (18)F-FMISO PET, and (18)F-FLT PET in relation to contrast enhancement in newly diagnosed glioblastoma.
    J Nucl Med. 2021 May 20. pii: jnumed.120.249524. doi: 10.2967/jnumed.120.249524.
    PubMed     Abstract available
    
    
    January 2021
19. JIMENEZ-FRANCO LD, Glatting G, Prasad V, Weber WA, et al
    Effect of Tumor Perfusion and Receptor Density on Tumor Control Probability in (177)Lu-DOTATATE Therapy: An In Silico Analysis for Standard and Optimized Treatment.
    J Nucl Med. 2021;62:92-98.
    PubMed     Abstract available
    
    
    November 2020
20. CECCON G, Lohmann P, Werner JM, Tscherpel C, et al
    Early treatment response assessment using (18)F-FET PET compared to contrast-enhanced MRI in glioma patients following adjuvant temozolomide chemotherapy.
    J Nucl Med. 2020 Nov 6. pii: jnumed.120.254243. doi: 10.2967/jnumed.120.254243.
    PubMed     Abstract available
    
    
    May 2020
21. KRAMER K, Donzelli M, Nwora E, Pandit-Taskar N, et al
    Assessing Cerebrospinal Fluid Flow Dynamics in Pediatric Patients with Central Nervous System Tumors Treated with Intraventricular Radioimmunotherapy.
    J Nucl Med. 2020;61:662-664.
    PubMed     Abstract available
    
    
    April 2020
22. HERHAUS P, Lipkova J, Lammer F, Yakushev I, et al
    CXCR4-targeted positron emission tomography imaging of central nervous system B-cell lymphoma.
    J Nucl Med. 2020 Apr 24. pii: jnumed.120.241703. doi: 10.2967/jnumed.120.241703.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: